Table 1 General characteristics of the study population
Variables | Patients (n = 67) | Controls (n = 14) | p |
|---|---|---|---|
Age (years) | 57 ± 12 | 56 ± 10 | 0.74 |
Male (%) | 50 (74) | 9 (64) | 0.31 |
BMI (kg/m2) | 25.8 ± 4.6 | 24.4 ± 3.7 | 0.24 |
SBP (mmHg) | 118 ± 17 | 124 ± 12 | 0.13 |
DBP (mmHg) | 63 ± 12 | 68 ± 7 | 0.075 |
HR (bpm) | 68 ± 11 | 68 ± 8 | 0.94 |
RPP | 8034 ± 1713 | 8558 ± 1233 | 0.26 |
Hypertension (%) | 38 (57) | 9 (64) | 0.42 |
Dyslipidemia (%) | 34 (51) | 8 (57) | 0.44 |
Diabetes treatment | |||
 Diet (%) | 10 (15) | – |  |
 Sulfonylurea (%) | 11 (16) | – |  |
 Glinide (%) | 9 (13) | – |  |
 Biguanide (%) | 22 (33) | – |  |
 Thiazolidinedione (%) | 9 (13) | – |  |
 α-glucosidase inhibitor (%) | 23 (34) | – |  |
 Insulin (%) | 34 (51) | – |  |
Other treatment | |||
 Statin (%) | 30 (45) | 5 (36) | 0.38 |
 ACE inhibitor/ARB (%) | 34 (51) | 5 (36) | 0.23 |
 CCB (%) | 23 (34) | 7 (50) | 0.21 |